High levels of a blood protein called clusterin are linked to the development of Alzheimer's disease, scientists said on Monday -- a finding which could pave the way for doctors to detect the disease before it takes hold.
Researchers from the Institute of Psychiatry at King's College London said that while doctors are around 5 years away from being able to use the discovery for a test to identify future Alzheimer's sufferers, it was a big step along the way.
Alzheimer's is the most common form of dementia -- a brain-wasting condition that affects around 35 million people around the world -- and despite decades of research, doctors still have few effective weapons against it.
Click to expand...